Valneva (VALN) reported $197M in revenue for fiscal 2025, +7.5% year on year. That ranks #2666 by revenue among 2853 SEC filers and #285 in Healthcare. It posted a net loss of −$130M for the same year. Revenue has grown 5.7% a year on average since 2019 ($141M then). The fiscal 2025 balance sheet shows $469M in total assets, $129M in cash and $189M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| Revenue€175M | $197M | +7.5% | FY20252025-12-31 |
| Gross profit | Not reported | — | |
| Operating income−€82.1M | −$92.7M | −$107M | FY20252025-12-31 |
| Net income−€115M | −$130M | −$117M | FY20252025-12-31 |
| Operating cash flow−€52.9M | −$59.8M | +$13.0M | FY20252025-12-31 |
| Capital expenditure€4.4M | $5.0M | −66.7% | FY20252025-12-31 |
| Total assets€399M | $469M | −9.8% | FY20252025-12-31 |
| Shareholders' equity€106M | $125M | −33.8% | FY20252025-12-31 |
| Cash€110M | $129M | −26.3% | FY20252025-12-31 |
| Long-term debt€161M | $189M | +9.5% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.
Profile
- Legal name
- Valneva Se
- Ticker
- VALN
- Exchange
- Nasdaq
- SIC classification
- Biological Products, (No Diagnostic Substances) (2836)
- Fiscal year end
- 12-31
- CIK
- 0001836564
Filings
- 20-FMar 17, 2026Open filing →
- 20-FMar 24, 2025Open filing →
- 20-FMar 22, 2024Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Establishment LabsESTA | $211M | −$51.1M |
| Canopy GrowthCGC | $204M | −$189M |
| Si-BoneSIBN | $201M | −$18.9M |
| ValnevaVALN | $197M | −$130M |
| Strata Critical MedicalSRTA | $197M | $41.3M |
| LifemdLFMD | $194M | −$11.2M |
| Lakeland IndustriesLAKE | $193M | −$25.3M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Valneva — Key figures |url=https://companiesranked.com/en/company/valneva |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Valneva — Key figures. CompaniesRanked. https://companiesranked.com/en/company/valnevaBibTeX
@misc{companiesranked-en-company-valneva-2026,
author = {{CompaniesRanked}},
title = {{Valneva — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/valneva}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001628280-26-018808 · March 17, 2026
{{cite web |title=Valneva — Key figures — 20-F (0001628280-26-018808) |url=https://www.sec.gov/Archives/edgar/data/1836564/000162828026018808/valn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.